Combined experience of six independent laboratories attempting to create an Ewing sarcoma mouse model TZ Minas, D Surdez, T Javaheri, M Tanaka, M Howarth, HJ Kang, J Han, ... Oncotarget 8 (21), 34141, 2017 | 93 | 2017 |
Evaluation of the protective effects of quercetin, rutin, naringenin, resveratrol and trolox against idarubicin-induced DNA damage H Çelik, E Arinç University of Alberta Libraries, 2010 | 71 | 2010 |
A small molecule inhibitor of ETV1, YK-4-279, prevents prostate cancer growth and metastasis in a mouse xenograft model S Rahim, T Minas, SH Hong, S Justvig, H Çelik, YS Kont, J Han, ... PLoS One 9 (12), e114260, 2014 | 70 | 2014 |
Ezrin inhibition up-regulates stress response gene expression and blocks osteosarcoma metastasis H Çelik, G Bulut, J Han, GT Graham, TZ Minas, EJ Conn, SH Hong, ... Cancer Research 76 (14 Supplement), 2446, 2016 | 54* | 2016 |
Ezrin inhibition up-regulates stress response gene expression H Çelik, G Bulut, J Han, GT Graham, TZ Minas, EJ Conn, SH Hong, ... Journal of Biological Chemistry, 2016 | 54 | 2016 |
Inhibitory effects of dietary flavonoids on purified hepatic NADH-cytochrome b5 reductase: Structure–activity relationships H Çelik, M Koşar Chemico-biological interactions 197 (2-3), 103-109, 2012 | 52 | 2012 |
Highly multiplexed proteomic assessment of human bone marrow in acute myeloid leukemia H Çelik, KE Lindblad, B Popescu, G Gui, M Goswami, J Valdez, ... Blood Advances 4 (2), 367-379, 2020 | 40 | 2020 |
Ezrin binds to DEAD-box RNA helicase DDX3 and regulates its function and protein level H Çelik, KP Sajwan, AV Pai, BJ Marsh, YS Kont, S Rahim, J Han, T Minas, ... Cancer Research 75 (15 Supplement), 3269, 2015 | 39 | 2015 |
Gene expression profile regulated by the HPV16 E7 oncoprotein and estradiol in cervical tissue EM Cortés-Malagón, J Bonilla-Delgado, J Díaz-Chávez, ... Virology 447 (1-2), 155-165, 2013 | 39 | 2013 |
Ezrin enhances EGFR signaling and modulates erlotinib sensitivity in non–small cell lung cancer cells Y Saygideğer-Kont, TZ Minas, H Jones, S Hour, H Çelik, I Temel, J Han, ... Neoplasia 18 (2), 111-120, 2016 | 34 | 2016 |
Bioreduction of idarubicin and formation of ROS responsible for DNA cleavage by NADPH-cytochrome P450 reductase and its potential role in the antitumor effect H Çelik, E Arinç Journal of Pharmacy & Pharmaceutical Sciences 11 (4), 68-82, 2008 | 33 | 2008 |
Clofarabine inhibits Ewing sarcoma growth through a novel molecular mechanism involving direct binding to CD99 H Çelik, M Sciandra, B Flashner, E Gelmez, N Kayraklıoğlu, ... Oncogene, 1, 2018 | 32 | 2018 |
YK-4-279 effectively antagonizes EWS-FLI1 induced leukemia in a transgenic mouse model TZ Minas, J Han, T Javaheri, SH Hong, M Schlederer, Y Saygideğer-Kont, ... Oncotarget 6 (35), 37678, 2015 | 29 | 2015 |
Identification of novel ezrin inhibitors targeting metastatic osteosarcoma by screening open access malaria box H Çelik, SH Hong, DD Colón-López, J Han, YS Kont, TZ Minas, M Swift, ... Molecular Cancer Therapeutics, 2015 | 28 | 2015 |
Biochemical characteristics of purified beef liver NADPH–cytochrome P450 reductase E Arinç, H Ļelik Journal of Biochemical and Molecular Toxicology 16 (6), 286-297, 2002 | 22 | 2002 |
Early synergistic interactions between the HPV16‑E7 oncoprotein and 17β-oestradiol for repressing the expression of Granzyme B in a cervical cancer model JA Munguía-Moreno, J Díaz‑Chavéz, E García-Villa, ME Albino-Sanchez, ... International journal of oncology 53 (2), 579-591, 2018 | 21 | 2018 |
In vitro effects of myricetin, morin, apigenin,(+)-taxifolin,(+)-catechin,(−)-epicatechin, naringenin and naringin on cytochrome b5 reduction by purified NADH-cytochrome b5 … H Çelik, M Koşar, E Arinç Toxicology 308, 34-40, 2013 | 15 | 2013 |
Human papillomavirus type 16 E7 oncoprotein upregulates the retinoic acid receptor-beta expression in cervical cancer cell lines and K14E7 transgenic mice J Gutiérrez, E García-Villa, R Ocadiz-Delgado, EM Cortés-Malagón, ... Molecular and Cellular Biochemistry, 1-12, 2015 | 10 | 2015 |
Mechanisms and involvements of NADPH-cytochrome P450 reductase and NADH-cytochrome b5 reductase in mitomycin c and idarubicin promoted DNA damage and" ros" formation: A study … H Celik, E Arinc | 6 | 2006 |
Comparison of the in vitro DNA-damaging potential of the two anticancer drugs idarubicin and mitomycin C in the presence of NADPH-cytochrome P450 reductase H Celik, E Arinc | 6 | 2006 |